Trials / Sponsors / Deepa Jagadeesh
Deepa Jagadeesh
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | ME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma | Phase 1 / Phase 2 | 2021-04-28 |
| Terminated | Rituximab and Acalabrutinib in Newly Diagnosed B Cell Post Transplant Lymphoproliferative Disorder Post-transplant Lymphoproliferative Disorder | Phase 2 | 2020-09-02 |
| Completed | A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymp T-cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepato-splenic T-cell Lymphoma | Phase 2 | 2016-06-17 |